Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis

Medical Science Monitor

Volumn 16, Issue 2, 2010, Pages

  Skubala, Alina ^a   Zywiec, Joanna ^a   Zełobowska, Katarzyna ^a   Gumprecht, Janusz ^a   Grzeszczak, Władysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

CGMS; Diabetes mellitus; Glucose based dialysate; Peritoneal dialysis

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC INDEX; HUMAN; KIDNEY FAILURE; MALE; PERITONEAL FLUID;

BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 76049087824     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. U.S. Renal Data System: U.S. Renal Data System 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
2. Wolfe RA, Ashby VB, Milford EL et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med, 1999; 341: 1725-30
3. Grassmann A, Gioberge S, Moeller S, Brown G: ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant, 2005; 20(12): 2587-93
4. Gamba G, Mejia JL, Saldivar S et al: Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron, 1993; 65: 23-27
5. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R: Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int, 2001; 21: 148-53
6. Avram MM, Mittman N, Bonomini L et al: Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis, 1995; 26: 209-19
7. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074
8. Johnson JG, Gore SM, Firth J: The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant, 1999; 14: 2156-64
9. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol, 1999; 10: 1606-15
10. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998; 3 2(Suppl.3): S112-19
11. Best PJ, Holmes DR: Chronic kidney disease as a cardiovascular risk factor. Am Heart J, 2003; 145: 383-86
12. Go AS, Chertow GM, Fan D et al: Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med, 2004; 351: 1296-305
13. Guzon O, Dellsperger K: Cardiovascular issues in dialysis patients: challenges and newer insights. Adv Perit Dial, 2006; 22: 111-15
14. http://www.kidney.org/professionals/KDOQI/guidelines-cvd/guide11. htm
15. Balkau B, Shipley M, Jarrett RJ et al: High blood glucose concentration is a risk factor for mortality in middle-aged non diabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 1998; 21: 360-67
16. Popovich RP, Moncrief JW, Dechert JF et al: The definition of a novel portable-wearable equilibrium dialysis technique (abstract). Trans Am Soc Artif Intern Organs, 1976; 5: 64
17. Szeto CC, Chow KM, Leung CB, Li PK: New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis, 2007; 49: 524-32
18. Kronenberg F, Konig P, Neyer U et al: Multicenter study of lipoprotein (a) and apolipoprotein (a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol, 1995; 6: 110-20
19. Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int, 2000; 20(Suppl.2): S37-41
20. Fuchs C, Armstrong VW, Dorn D et al: Biochemical changes with continuous ambulant peritoneal dialysis (CAPD). Urol Nephrol, 1982; 75: 415-27
21. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329: 977-86
22. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998; 352: 837-53
23. Tzamaloukas AH, Murata GH, Zager PG et al: The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. ASAIO J, 1993; 39: 880-85
24. Morika T, Emoto M, Tabata T et al: Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care, 2001; 24: 909-13
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP).Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-97
26. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia, 2001; 44: 2107-14
27. Hirsh IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diab Complic, 2005; 19: 178-81
28. Hirsh IB: Intensifying insulin therapy in patients with type 2 diabetes mellitus. Am J Med, 2005; 118(Suppl.5A): 21S-26S
29. Haffner S: The importance of hyperglycemia in the fasting state to the development of cardiovascular disease. Endocr Rev, 1998; 19: 583-92
30. Gerich JE: Clinical significance, pathogenesis and management of postprandial hyperglycemia. Arch Intern Med, 2003; 163: 1306-18
31. Rodriguez BL, Lau N, Burchfiel CM et al: Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care, 1999; 22: 1262-65
32. Hanefeld M, Fisher S, Julius U et al: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia, 1996; 39: 1577-83
33. The DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 1999; 354: 617-21
34. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW: Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care, 2002; 25: 1845-50
35. Shichiri M, Kishikawa H, Ohkubo Y et al: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care, 2000; 23(Suppl.2): B21-B29
36. Hanefeld M, Koehler C, Schaper F et al: Postprandial plasma glucose is an independent risk factor for increased carotid intima media thickness in non-diabetic individuals. Atherosclerosis, 1999; 144: 229-35
37. Ansari A, Thomas S, Goldsmith D: Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis, 2003; 41: 523-31
38. Ly J, Marticorena R, Donnelly S: Red blood cell survival in chronic renal failure. Am J Kidney Dis, 2004; 44: 715-19
39. Joy MS, Cefalu WT, Hogan SL, Nachman PH: Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis, 2002; 39: 297-307
40. Lindholm B, Karlander SG: Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis. Acta Med Scand, 1986; 220(5): 477-83
41. Heaton A, Johnston DG, Haigh JW et al: Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis. Clin Sci (Lond), 1985; 69: 449-57
42. Schwing WD, Erhard P, Newman LN et al: Assessing 24-hour blood glucose patterns in diabetic patients treated by peritoneal dialysis. Adv Perit Dial, 2004; 20: 213-16
43. Marshall J, Jennings P, Scott A et al: Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (cgms). Kidney Int, 2003; 64: 1480-86
44. Fortes P, Mendes J, Gevert F et al: Continuous Glycemic Monitoring System (CGMS) Utility in Diabetic Patients Undergoing Peritoneal Dialysis Perit Dial Int, 2007; 27(Suppl.3): 14
45. Armstrong VW, Creutzfeldt W, Ebert R et al: Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients. Nephron, 1985; 39(2): 141-45
46. Twardowski ZJ, Nolph KD, Khanna R et al: Peritoneal Equilibration Test. Perit Dial Int, 1987; 7(3): 138-47
47. Raj DS, Langos V, Gangam N, Roscoe J: Ethnic variability in peritoneal equilibration test and urea kinetics. Am J Kidney Dis, 1997; 30(3): 374-81
48. Cueto-Manzano AM, Diaz-Alvarenga A, Correa-Rotter R: Analysis of the peritoneal equilibration test in Mexico and factors influencing the peritoneal transport rate. Perit Dial Int, 1999; 19(1): 45-50
49. Wong FK, Li CS, Mak CK et al: Peritoneal equilibration test in Chinese patients. Adv Perit Dial, 1994; 10: 38-41
50. Chakravarthy R, Surjit S, Prakash KC et al: Pattern of peritoneal permeability in Indian CAPD population. J Indian Soc Perit Dial, 2002; 4: 19-23
51. Lin JJ, Wadhwa NK, Suh H et al: Increased peritoneal solute transport in diabetic peritoneal dialysis patients. Adv Perit Dial, 1995; 11: 63-66
52. Lamb EJ, Worrall J, Buhler R et al: Effect of diabetes and peritonitis on the peritoneal equilibration test. Kidney Int, 1995; 47(6): 1760-67
53. Krediet RT: The peritoneal membrane in chronic peritoneal dialysis. Kidney Int, 1999; 55(1): 341-56
54. Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest, 1987; 17(1): 43-52
55. Khanna R: Peritoneal inflammation and high transport status. Clin J Am Soc Nephrol, 2006; 1(2): 167-69
56. Rebrin K, Steil G: Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther, 2000; 2(3): 461-72
57. Djakoure-Platonoff C, Radermercker R, Reach G et al: Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab, 2003; 29: 159
58. Gross T, Bode B, Einhorn D et al: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther, 2000; 2(1): 49-56
59. Sachedina N, Pickup J: Performance assessment of the Medtronic-MiniMed Continuous Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diab Med, 2003; 20: 1012-15